Trial intelligence / Profile preview

Impact of Persistent Conductances on Motor Unit Firing in SCI

NCT02136823Unknown

Sponsor
Shirley Ryan AbilityLab
Start
Jun 2009
Primary completion
May 2015
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of riluzole, Isradipine and memantine in spinal cord injury (SCI), sponsored by Shirley Ryan AbilityLab. Status: unknown.

02

Drugs

riluzoleIsradipinememantine
03

Conditions

spinal cord injury (SCI)

Beyond the preview

Go deeper on NCT02136823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02136823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call